<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759143/" ref="ordinalpos=1749&amp;ncbi_uid=2044640&amp;link_uid=PMC2759143" image-link="/pmc/articles/PMC2759143/figure/f3-grsb-2007-217/" class="imagepopup">Figure 3.  From: <span class="highlight" style="background-color:">Signaling</span> Mechanisms of Endogenous Angiogenesis Inhibitors Derived from Type IV Collagen. </a></div><br /><div class="p4l_captionBody">Schematic illustration of different signaling pathway mediated by α3(IV)NC1. α3(IV)NC1 binds to αVβ3 and α3β1 integrins, and inhibits phosphorylation of FAK. Inhibition of FAK activation leads to inhibition of FAK/PI-3K/eIF4E/4E-BP1 cap dependent translation. In addition α3(IV)NC1 inhibits NFκB mediated signaling in hypoxic conditions leading to inhibition of COX-2/VEGF/bFGF expression, resulting in inhibition of hypoxic tumor angiogenesis.</div></div>